|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9200 EUR | +1.77% |
|
-1.29% | +54.36% |
| 06-11 | Triple update for Biosynex |  |
| 06-11 | An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOSYNEX | Diagnostic & Testing Substances | +1.77% | -1.29% | +54.36% | -30.83% | -95.67% | 19.18M |  | | |
- Stock Market
- Stocks
- ALBIO Stock
- Charts Biosynex
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
